Amongst the 28,446 tumor-specific pHLAs, we highlighted a highly recurrent, abundant, and tumor-specific HAVCR1-derived peptide in clear cell renal cell carcinoma, an ideal PC-CAR target, providing an alternative strategy to avoid the ectodomain shedding for conventional CAR. This evidence concerns the gene HAVCR1 and neoplasm.